Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)
China
· Delayed Price · Currency is CNY 3.600
+0.010 (0.28%)
Mar 10, 2026, 3:04 PM CST
SHE:300026 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 10,785 | 11,386 | 12,738 | 17,064 | 23,523 | 13,759 | Upgrade
|
| Market Cap Growth | -4.27% | -10.61% | -25.35% | -27.46% | 70.96% | 30.42% | Upgrade
|
| Enterprise Value | 10,178 | 11,349 | 13,109 | 18,344 | 24,054 | 14,108 | Upgrade
|
| Last Close Price | 3.59 | 3.76 | 4.17 | 5.56 | 7.61 | 4.41 | Upgrade
|
| PE Ratio | - | 530.38 | 25.14 | 27.34 | 34.22 | 24.00 | Upgrade
|
| Forward PE | - | 16.83 | 16.83 | 16.83 | 16.83 | 16.83 | Upgrade
|
| PS Ratio | 1.96 | 1.97 | 2.09 | 2.57 | 3.07 | 2.12 | Upgrade
|
| PB Ratio | 1.23 | 1.29 | 1.44 | 2.02 | 2.96 | 1.86 | Upgrade
|
| P/TBV Ratio | 1.40 | 1.48 | 1.66 | 2.36 | 3.49 | 2.23 | Upgrade
|
| P/FCF Ratio | 15.29 | 17.27 | 10.77 | - | - | - | Upgrade
|
| P/OCF Ratio | 12.20 | 13.36 | 8.32 | 22.89 | 60.07 | 69.96 | Upgrade
|
| PEG Ratio | - | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 | Upgrade
|
| EV/Sales Ratio | 1.85 | 1.96 | 2.15 | 2.76 | 3.14 | 2.17 | Upgrade
|
| EV/EBITDA Ratio | 24.52 | 29.32 | 16.23 | 18.83 | 19.77 | 15.27 | Upgrade
|
| EV/EBIT Ratio | 119.10 | 110.81 | 25.43 | 25.32 | 24.00 | 19.22 | Upgrade
|
| EV/FCF Ratio | 14.43 | 17.22 | 11.08 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.10 | 0.17 | 0.25 | 0.25 | 0.16 | Upgrade
|
| Debt / EBITDA Ratio | 1.57 | 1.95 | 1.78 | 2.03 | 1.55 | 1.25 | Upgrade
|
| Debt / FCF Ratio | 0.92 | 1.29 | 1.30 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.09 | -0.05 | 0.00 | 0.11 | 0.08 | 0.01 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.10 | -1.17 | -0.05 | 0.91 | 0.53 | 0.04 | Upgrade
|
| Net Debt / FCF Ratio | -1.08 | -0.69 | -0.03 | -35.48 | -2.27 | -0.09 | Upgrade
|
| Asset Turnover | 0.50 | 0.50 | 0.50 | 0.55 | 0.70 | 0.70 | Upgrade
|
| Inventory Turnover | 1.58 | 1.51 | 1.35 | 1.61 | 2.40 | 2.48 | Upgrade
|
| Quick Ratio | 3.05 | 2.57 | 2.89 | 1.79 | 2.46 | 1.72 | Upgrade
|
| Current Ratio | 4.26 | 3.79 | 4.29 | 2.76 | 3.31 | 2.44 | Upgrade
|
| Return on Equity (ROE) | -0.87% | 0.26% | 5.79% | 7.57% | 8.74% | 7.74% | Upgrade
|
| Return on Assets (ROA) | 0.48% | 0.56% | 2.63% | 3.73% | 5.75% | 4.93% | Upgrade
|
| Return on Invested Capital (ROIC) | 1.06% | 0.51% | 4.69% | 7.00% | 9.83% | 8.66% | Upgrade
|
| Return on Capital Employed (ROCE) | 0.90% | 1.10% | 5.00% | 7.30% | 10.50% | 9.40% | Upgrade
|
| Earnings Yield | -0.61% | 0.19% | 3.98% | 3.66% | 2.92% | 4.17% | Upgrade
|
| FCF Yield | 6.54% | 5.79% | 9.29% | -0.15% | -1.21% | -2.67% | Upgrade
|
| Dividend Yield | 0.84% | 0.80% | 0.72% | 0.54% | 0.53% | 0.91% | Upgrade
|
| Payout Ratio | - | 638.70% | 30.53% | 30.56% | 22.96% | 31.73% | Upgrade
|
| Buyback Yield / Dilution | 27.37% | 27.97% | -0.26% | 0.53% | 0.98% | -4.96% | Upgrade
|
| Total Shareholder Return | 28.21% | 28.76% | 0.46% | 1.07% | 1.50% | -4.05% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.